Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting
- 27 Downloads
In order to improve the knowledge of the humoral immune response to CMV infection, we developed an immunoblotting technique which allowed a better analysis of the changes in the pattern of anti CMV-polypeptides IgM. We examined 234 sera belonging to 27 renal allograft recipients developing a primary or recurrent CMV infection and 12 non infected recipients. Thus we found that 11 main anti CMV-polypeptides IgM antibodies were present in over 25% of the infected patients. They reacted with proteins whose molecular weights ranged from 32K to 205 K.
We showed that anti-p 45–47 IgM antibodies were present in 100% of CMV infected recipients and never in the non-infected population. They appeared very early in the course of the infection (5.43 weeks post-graft for primary infection and 5.00 weeks for recurrent ones) and, therefore, constitute a good marker of active infection. Two other CMV-specific IgM antibodies (anti-p 60–64 and anti-p 100) were found exclusively in the course of primary infections. Anti-p 60–64 IgM was observed at a high frequency (57.1%) and with a mean delay of 6.57 weeks post-graft. Therefore, the anti-p 60–64 IgM detection could be helpful for the diagnosis of primary infection. In almost 100% of both primary and recurrent infections, we observed anti-p 140 and anti-p 38 IgM antibodies. Only about 50% of non-infected patients had low levels of anti-p 140 and anti-p 38 IgM.
The follow-up of recurrent infections showed that the anti CMV-polypeptides IgM antibodies appeared earlier than in primary infection. When we compared anti-p 45–47 IgM detection by immunoblotting and anti-CMV IgM detected by ELISA we observed that immunoblotting permitted the diagnosis 2.5 weeks earlier for primary infection, and 1 week earlier for recurrent infection, than ELISA. In addition, the detection of anti-p 45–47 IgM antibodies also occurred earlier than virus excretion.
KeywordsHumoral Immune Response Primary Infection Recurrent Infection Renal Allograft Good Marker
Unable to display preview. Download preview PDF.
- 1.Aymard M, Bosshard S, Chomel JJ, Gibert R, El Yasi M, Langlois M, Malik MC, Revillard JP, Tardy JC, Touraine JL, Traeger J (1982) Herpesvirus infections in patients with renal allografts. In: Touraine JL et al (eds) Transplantation and clinical immunology, vol 14. Excerpta Medica, Amsterdam, p 113–120Google Scholar
- 2.Fiala M, Honess RW, Heiner DC, Heine JW, Murnane J, Wallace R, Guze LB (1976) Cytomegalovirus proteins: I. polypeptides of virions and dense bodies. J Virol 19: 243–254Google Scholar
- 3.Forman SJ, Zaia JA, Clark BR, Wright CL, Mills BJ, Pottathil R, Racklin BC, Gallagher MT, Welte K, Blume KG (1985), A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune response similar to those of whole viral antigen. J Immunol 134: 3391–3395Google Scholar
- 4.Gibson W (1981) Structural and non structural proteins of strain Colburn cytomegalovirus. Virology 111: 516–537Google Scholar
- 5.Gibson W (1983) Protein counterparts of human and simian cytomegaloviruses. Virology 128: 391–406Google Scholar
- 6.Glenn J (1981) Cytomegalovirus infections following renal transplantation. Rev Infect Dis 3: 1151–1173Google Scholar
- 7.Gupta P, St Jeor S, Rapp F (1977) Comparison of the polypeptides of several strains of human cytomegalovirus. J Gen Virol 34: 447–454Google Scholar
- 8.Horodniceanu F, Michelson S (1980) Assessment of human cytomegalovirus antibody detection technique. Brief Review. Arch Virol 64: 287–301Google Scholar
- 9.Kim KS, Sapienza VJ, Carp RJ, Moon HM (1976) Analysis of structural polypeptides of purified human cytomegalovirus. J Virol 20: 604–611Google Scholar
- 10.Laemmli UK (1970) Cleavage of structural proteins during the asssembly of the head of bacteriophage T 4. Nature 227: 680–685Google Scholar
- 11.Landini MP, Re MC, Mirolo G, Baldassarri B, La Placa M (1985) Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. J Med Virol 17: 303–311Google Scholar
- 12.Pereira L, Hoffman M, Cremer N (1982) Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera. Infect Immun 36: 933–942Google Scholar
- 13.Porath A, Hanuka N, Keynan A, Sarov I (1987) Virus-specific serum IgG, IgM and IgA antibodies in cytomegalovirus mononucleosis patients as determined by immunoblotting technique. J Med Virol 22: 223–230Google Scholar
- 14.Revello MG, Percivalle E, Gerna G (1986) Immunoglobulin M to the membrane of uninfected fibroblasts in primary human cytomegalovirus infections. Microbiologica 9: 127–138Google Scholar
- 15.Sarov I, Abady I (1975) The morphogenesis of human cytomegalovirus isolation and polypeptide characterization of cytomegalovirions and dense bodies. Virology 66: 464–473Google Scholar
- 16.Schmitz H, Muller-Lantzsch N, Peteler G (1980) Human response to proteins of cytomegalovirus. Intervirology 13: 154–161Google Scholar
- 17.Stinski MF (1978) Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus induced polypeptides. J Virol 26: 686–701Google Scholar
- 18.Tardy JC, Pouteil-Noble C. Touraine JL, Aymard M (1987) Prognostic value of anti cytomegalovirus IgM in kidney graft recipients. In: Brynger H (ed) Transplantation proceedings, vol 19. Grune and Stratton, Philadelphia, p 4066–4067Google Scholar
- 19.Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350–4354Google Scholar